Logo image of AVCT

AMERICAN VIRTUAL CLOUD TECHN (AVCT) Stock Fundamental Analysis

NASDAQ:AVCT - Nasdaq - US0303822045 - Common Stock - Currency: USD

0.598  -0.07 (-11.01%)

After market: 0.6 +0 (+0.33%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AVCT. AVCT was compared to 82 industry peers in the IT Services industry. No worries on liquidiy or solvency for AVCT as it has an excellent financial health rating, but there are worries on the profitability. AVCT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AVCT had negative earnings in the past year.
AVCT had a negative operating cash flow in the past year.
AVCT Yearly Net Income VS EBIT VS OCF VS FCFAVCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 -50M -100M -150M

1.2 Ratios

AVCT has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AVCT Yearly ROA, ROE, ROICAVCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 0 -5K -10K -15K

1.3 Margins

AVCT has a worse Gross Margin (5.46%) than 89.78% of its industry peers.
The Profit Margin and Operating Margin are not available for AVCT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AVCT Yearly Profit, Operating, Gross MarginsAVCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 0 -200 -400 -600 -800

More info and screens

7

2. Health

2.1 Basic Checks

AVCT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AVCT has less shares outstanding
Compared to 1 year ago, AVCT has an improved debt to assets ratio.
AVCT Yearly Shares OutstandingAVCT Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 10M 20M 30M
AVCT Yearly Total Debt VS Total AssetsAVCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

AVCT has an Altman-Z score of -17.50. This is a bad value and indicates that AVCT is not financially healthy and even has some risk of bankruptcy.
AVCT has a Altman-Z score of -17.50. This is amonst the worse of the industry: AVCT underperforms 96.35% of its industry peers.
There is no outstanding debt for AVCT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -17.5
ROIC/WACCN/A
WACC10.11%
AVCT Yearly LT Debt VS Equity VS FCFAVCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 0 100M 200M 300M

2.3 Liquidity

AVCT has a Current Ratio of 2.29. This indicates that AVCT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AVCT (2.29) is better than 76.64% of its industry peers.
AVCT has a Quick Ratio of 2.29. This indicates that AVCT is financially healthy and has no problem in meeting its short term obligations.
AVCT has a Quick ratio of 2.29. This is in the better half of the industry: AVCT outperforms 76.64% of its industry peers.
Industry RankSector Rank
Current Ratio 2.29
Quick Ratio 2.29
AVCT Yearly Current Assets VS Current LiabilitesAVCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

AVCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -126.62%.
The Revenue for AVCT has decreased by -58.64% in the past year. This is quite bad
EPS 1Y (TTM)-126.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.4%
Revenue 1Y (TTM)-58.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%14.22%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AVCT Yearly Revenue VS EstimatesAVCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 20M 40M 60M 80M 100M
AVCT Yearly EPS VS EstimatesAVCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 -10 -20 -30 -40 -50

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AVCT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVCT Price Earnings VS Forward Price EarningsAVCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AVCT Per share dataAVCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AVCT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN VIRTUAL CLOUD TECHN

NASDAQ:AVCT (1/19/2023, 8:09:50 PM)

After market: 0.6 +0 (+0.33%)

0.598

-0.07 (-11.01%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-25 2022-11-25/amc
Earnings (Next)N/A N/A
Inst Owners0.09%
Inst Owner Change0%
Ins Owners95.61%
Ins Owner Change0%
Market Cap19.42M
Analysts82.86
Price Target7.14 (1093.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.6
P/FCF N/A
P/OCF N/A
P/B 1.11
P/tB 1.11
EV/EBITDA N/A
EPS(TTM)-72.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.27
FCFYN/A
OCF(TTM)-2.23
OCFYN/A
SpS1
BVpS0.54
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.46%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 57.88%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.29
Quick Ratio 2.29
Altman-Z -17.5
F-Score4
WACC10.11%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-126.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-58.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%14.22%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-71.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-427.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-432.2%
OCF growth 3YN/A
OCF growth 5YN/A